The global leap: Chinese biopharma, athletic brands dip toes in global waters
"To out-license drugs is a very handy and clever way for a win-win… but in terms of acquiring the businesses, that's going to be really tough." – Bradley Burgess Key…
Recent Articles
RELATED ARTICLES
-
China’s biopharma sector enters the New Year on a high
- Regulatory caution dims Hong Kong SPAC outlook, while Chinese tastes drive out foreign brands
- Global brands use overseas, emotional connections to navigate cutthroat China F&B market
- Chando joins growing bevy of Chinese beauty brands at IPO ball
-
Xtep races ahead on Southeast Asia running craze
1368.HK
- Big deal, bigger doubts: CSPC slides after $18.5 billion pact
